This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Astrazeneca Ab. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Andrew David Chapman
Introduction
Andrew David Chapman is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of medical technology, particularly with his innovative designs and solutions. His work has been recognized within the industry, showcasing his dedication to improving healthcare through technology.
Latest Patents
Andrew holds a patent for a medical injector, which represents a significant advancement in the delivery of medications. This invention aims to enhance the efficiency and effectiveness of medical treatments, providing healthcare professionals with better tools to serve their patients.
Career Highlights
Currently, Andrew is employed at AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to work on cutting-edge projects that aim to improve patient outcomes through innovative medical solutions. His expertise and commitment to research and development have made him a valuable asset to the company.
Collaborations
Andrew has collaborated with several talented individuals in his field, including Michael James Herd and Thomas James Etheridge. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking technologies.
Conclusion
In summary, Andrew David Chapman is a distinguished inventor whose work in medical technology has the potential to transform patient care. His contributions, particularly in the development of the medical injector, highlight his commitment to innovation and excellence in the healthcare industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
